Outpatient Oncology Infusion Global Market Report 2025
상품코드:1810987
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
외래 종양학 주입 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.6%로 188억 1,000만 달러에 달할 전망입니다. 예측 기간의 성장은 고령 인구 증가, 개인 맞춤형 의료에 대한 수요 증가, 바이오시밀러 채택 증가, 비용 억제에 대한 강조, 금액 기준 상환 모델로의 전환, 종양 치료의 지속적인 인력 부족 등에 기인하는 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 수액 장치 기술의 발전, 원격 의료 서비스 통합, 원격 환자 모니터링 솔루션 도입, 개인 맞춤형 의료의 발전, 표적 암 치료의 혁신 등이 있습니다.
암 환자 유병률 증가는 향후 몇 년 동안 외래 종양학 주입 치료 시장의 성장을 가속할 것으로 예측됩니다. 암은 통제할 수 없는 비정상적인 세포의 증식을 특징으로 하는 여러 가지 복잡한 질환으로 구성되며, 주변 조직으로 침범하거나 신체의 다른 부위로 전이될 수 있습니다. 암 환자 증가는 전 세계적으로 인구 고령화가 주요 원인이며, 암 발병 가능성은 나이가 들수록 현저하게 증가하기 때문입니다. 외래 종양 수액요법에서는 입원하지 않고 임상 현장에서 화학요법, 면역요법, 분자표적치료 등의 암 치료를 할 수 있습니다. 이를 통해 환자는 일상생활을 유지하면서 치료를 받을 수 있습니다. 예를 들어, 2024년 4월 영국의 암 환자 지원 자선단체인 맥밀런 캔서 서포트(Macmillan Cancer Support)는 영국에서 암을 앓고 있는 사람의 수가 현재 300만 명을 넘어섰고, 2025년에는 350만 명, 2030년에는 400만 명, 2040년에는 530만 명에 달할 것으로 예측했습니다. 그 결과, 암 발병률 증가는 외래 종양학 주입 치료 시장 수요를 촉진하고 있습니다.
외래 종양학 주입 치료 시장에서 사업을 전개하는 기업들은 첨단 소프트웨어와 투약 오류 감소 시스템을 사용하여 약물 전달의 정확성을 높이고, 환자의 안전성을 높이며, 외래 암 치료를 간소화하기 위해 주사기 주입 펌프와 같은 신흥국 시장을 개척하고 있습니다. 주사기 주입 펌프(주사기 드라이버)는 주사기의 플런저를 설정된 속도로 움직여 주입액을 정확하게 제어하는 전동 장치입니다. 예를 들어, 2022년 8월, 미국의 수액 및 수술 기술 전문 헬스케어 기업 박스터 인터내셔널(Baxter International)은 Dose IQ Safety Software와 통합된 Novum IQ Syringe Infusion Pump(SYR)에 대한 FDA 승인을 획득했습니다. 이 시스템은 맞춤형 약물 라이브러리와 웹 기반 플랫폼을 갖추고 있으며, 투여 오류를 최소화하고 임상의가 약물 데이터에 대한 중앙 집중식 실시간 액세스를 제공하도록 설계되었습니다. 종양수액센터와 같은 외래 환자들을 위해 설계된 이 장치는 다양한 임상 환경에서 정확하고 프로그램 가능한 치료 투여를 가능하게 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계 성장 분석과 전략 분석 프레임워크
세계의 외래 종양학 주입 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 외래 종양학 주입 치료 시장 : 성장률 분석
세계의 외래 종양학 주입 치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 외래 종양학 주입 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 외래 종양학 주입 치료 : 전체 시장(TAM)
제6장 시장 세분화
세계의 외래 종양학 주입 치료 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
주입 펌프
정맥주사 세트
정맥 캐뉼라
무바늘 커넥터
세계의 외래 종양학 주입 치료 시장 : 요법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
화학요법
표적치료
면역치료
호르몬 요법
세계의 외래 종양학 주입 치료 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
폐암
간암
유방암
전립선암
기타 암
세계의 외래 종양학 주입 치료 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
외래 클리닉
홈케어
세계의 외래 종양학 주입 치료 시장 : 주입 펌프별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
용적식 주입 펌프
시린지 주입 펌프
엘라스토머 주입 펌프
휴대형 주입 펌프
스마트 주입 펌프
세계의 외래 종양학 주입 치료 시장 : 정맥주사 세트별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
Vented IV Sets
Non-Vented IV Sets
Gravity IV Sets
Pump-Compatible IV Sets
Filtered IV Sets
세계의 외래 종양학 주입 치료 시장 : 정맥 캐뉼라별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
말초 정맥 캐뉼라
중심 정맥 캐뉼라
Winged IV 캐뉼라(버터플라이)
폐쇄형 IV 캐뉼라
안전 IV 캐뉼라
세계의 외래 종양학 주입 치료 시장 : 무바늘 커넥터별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
Positive Displacement Connectors
Negative Displacement Connectors
Neutral Displacement Connectors
Closed System Transfer Devices (CSTDs)
Anti-Reflux Connectors
제7장 지역별/국가별 분석
세계의 외래 종양학 주입 치료 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 외래 종양학 주입 치료 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
외래 종양학 주입 치료 시장 : 경쟁 구도
외래 종양학 주입 치료 시장 : 기업 개요
Medtronic plc
Becton Dickinson and Company
Baxter International Inc.
Fresenius Kabi AG
Terumo Corporation
제31장 기타 주요 기업 및 혁신 기업
Nipro Corporation
Smiths Medical Inc.
ICU Medical Inc.
B. Braun Melsungen AG
InfuSystem Holdings Inc.
BPL Medical Technologies Private Limited
Angiplast Private Limited
Bio-Med Healthcare Products Private Limited
Lars Medicare Private Limited
Micrel Medical Devices S.A.
AKAS Infusions Private Limited
Mais India Medical Devices Private Limited
Wellead Medical Co. Ltd.
AdvaCare Pharma USA LLC
Polymed Medical Devices Private Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
외래 종양학 주입 치료 시장, 2029년 : 새로운 기회를 제공하는 국가
외래 종양학 주입 치료 시장, 2029년 : 새로운 기회를 제공하는 부문
외래 종양학 주입 치료 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Outpatient oncology infusion refers to the delivery of cancer-fighting medications in non-hospital settings, such as infusion centers or clinics. This approach aims to offer effective, convenient, and cost-efficient cancer treatment while reducing the need for prolonged hospital stays.
The primary product types used in outpatient oncology infusion include infusion pumps, intravenous (IV) sets, intravenous cannulas, and needleless connectors. Infusion pumps are medical devices that administer precise amounts of fluids-such as medications or nutrients-into a patient's body over a controlled timeframe. These products support various therapies, including chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. They are applied in treating conditions such as lung cancer, liver cancer, breast cancer, prostate cancer, and others, and serve end users such as hospitals, outpatient clinics, and home care settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The outpatient oncology infusion market research report is one of a series of new reports from The Business Research Company that provides outpatient oncology infusion market statistics, including the outpatient oncology infusion industry global market size, regional shares, competitors with the outpatient oncology infusion market share, detailed outpatient oncology infusion market segments, market trends, and opportunities, and any further data you may need to thrive in the outpatient oncology infusion industry. This outpatient oncology infusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The outpatient oncology infusion market size has grown strongly in recent years. It will grow from $12.99 billion in 2024 to $14.02 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. Growth during the historic period can be attributed to the rising incidence of cancer, the expansion of outpatient care centers, increased patient preference for more comfortable, home-like treatment settings, broader insurance coverage, a shift from inpatient to outpatient care models, and improving cancer survival rates.
The outpatient oncology infusion market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. Growth in the forecast period can be attributed to the expanding elderly population, increasing demand for personalized medicine, rising adoption of biosimilars, a stronger focus on cost containment, the shift toward value-based reimbursement models, and ongoing workforce shortages in oncology care. Key trends expected during this period include advancements in infusion device technology, integration of telehealth services, implementation of remote patient monitoring solutions, progress in personalized medicine, and innovations in targeted cancer therapies.
The increasing prevalence of cancer cases is expected to drive the growth of the outpatient oncology infusion market in the coming years. Cancer comprises a range of complex diseases characterized by the uncontrolled growth of abnormal cells that can invade nearby tissues and spread to other parts of the body. The rise in cancer cases is largely due to aging populations globally, as the likelihood of developing cancer increases significantly with age. Outpatient oncology infusion allows for the administration of cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in clinical settings without requiring hospital stays. This enables patients to receive treatment while continuing their daily routines. For example, in April 2024, Macmillan Cancer Support, a UK-based charity supporting people affected by cancer, projected that the number of individuals living with cancer in the UK would surpass 3 million currently, rise to 3.5 million by 2025, 4 million by 2030, and reach 5.3 million by 2040. As a result, the growing prevalence of cancer is fueling demand in the outpatient oncology infusion market.
Companies operating in the outpatient oncology infusion market are developing advanced products such as syringe infusion pumps to improve the accuracy of medication delivery, enhance patient safety, and streamline outpatient cancer care using sophisticated software and dose error reduction systems. Syringe infusion pumps, or syringe drivers, are motorized devices that precisely control fluid delivery by moving the plunger of a syringe at a set rate. For instance, in August 2022, Baxter International Inc., a US-based healthcare company specializing in infusion and surgical technologies, received FDA clearance for its Novum IQ Syringe Infusion Pump (SYR), integrated with Dose IQ Safety Software. This system features a customizable drug library and web-based platform designed to minimize dosing errors and provide clinicians with centralized, real-time access to medication data. Tailored for outpatient settings, including oncology infusion centers, the device delivers accurate and programmable administration of therapeutic agents across a variety of clinical environments.
In March 2022, Fresenius Kabi AG, a Germany-based pharmaceutical company, acquired Ivenix Inc. for $240 million. This acquisition enhances Fresenius Kabi's infusion therapy offerings by adding Ivenix's advanced smart infusion pump technologies to its portfolio. Ivenix Inc., a US-based medical device company, specializes in developing next-generation smart infusion systems used across outpatient and hospital settings, including oncology clinics.
Major players in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, and Polymed Medical Devices Private Limited.
North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in outpatient oncology infusion report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the outpatient oncology infusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The outpatient oncology infusion market consists of revenues earned by entities by providing services such as hormone therapy infusions, supportive care infusions, patient monitoring, patient education, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The outpatient oncology infusion market also includes sales of biosimilars, immunotherapy agents, supportive care drugs, infusion bags, IV poles, and stands. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Outpatient Oncology Infusion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on outpatient oncology infusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for outpatient oncology infusion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The outpatient oncology infusion market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
2) By Intravenous Sets: Vented IV Sets; Non-Vented IV Sets; Gravity IV Sets; Pump-Compatible IV Sets; Filtered IV Sets
3) By Intravenous Cannulas: Peripheral IV Cannulas; Central IV Cannulas; Winged IV Cannulas (Butterfly); Closed IV Cannulas; Safety IV Cannulas
4) By Needleless Connectors: Positive Displacement Connectors; Negative Displacement Connectors; Neutral Displacement Connectors; Closed System Transfer Devices (CSTDs); Anti-Reflux Connectors
Companies Mentioned: Medtronic plc; Becton Dickinson and Company; Baxter International Inc.; Fresenius Kabi AG; Terumo Corporation; Nipro Corporation; Smiths Medical Inc.; ICU Medical Inc.; B. Braun Melsungen AG; InfuSystem Holdings Inc.; BPL Medical Technologies Private Limited; Angiplast Private Limited; Bio-Med Healthcare Products Private Limited; Lars Medicare Private Limited; Micrel Medical Devices S.A.; AKAS Infusions Private Limited; Mais India Medical Devices Private Limited; Wellead Medical Co. Ltd.; AdvaCare Pharma USA LLC; Polymed Medical Devices Private Limited.
3. Outpatient Oncology Infusion Market Trends And Strategies
4. Outpatient Oncology Infusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Outpatient Oncology Infusion Growth Analysis And Strategic Analysis Framework
5.1. Global Outpatient Oncology Infusion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Outpatient Oncology Infusion Market Growth Rate Analysis
5.4. Global Outpatient Oncology Infusion Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Outpatient Oncology Infusion Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Outpatient Oncology Infusion Total Addressable Market (TAM)
6.1. Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infusion Pumps
Intravenous Sets
Intravenous Cannulas
Needleless Connectors
6.2. Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
6.3. Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Cancer
Liver Cancer
Breast Cancer
Prostate Cancer
Other Cancers
6.4. Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Outpatient Clinics
Home Care Settings
6.5. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Volumetric Infusion Pumps
Syringe Infusion Pumps
Elastomeric Infusion Pumps
Ambulatory Infusion Pumps
Smart Infusion Pumps
6.6. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vented IV Sets
Non-Vented IV Sets
Gravity IV Sets
Pump-Compatible IV Sets
Filtered IV Sets
6.7. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peripheral IV Cannulas
Central IV Cannulas
Winged IV Cannulas (Butterfly)
Closed IV Cannulas
Safety IV Cannulas
6.8. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Positive Displacement Connectors
Negative Displacement Connectors
Neutral Displacement Connectors
Closed System Transfer Devices (CSTDs)
Anti-Reflux Connectors
7. Outpatient Oncology Infusion Market Regional And Country Analysis
7.1. Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
